Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip microbiologystudyBy sharad / July 17, 2024 Antimicrobial Agents and Chemotherapy, Ahead of Print. Source link